| NCT07430319 | Centre Hospitalier Universitaire de Nice | Psoriasis | 2025-10-16 | |
| NCT03466411 | Janssen Research & Development, LLC | Crohn´s Disease | 2018-04-13 | PHASE2|PHASE3 |
| NCT03818035 | Janssen-Cilag International NV | Psoriasis | 2019-02-08 | PHASE3 |
| NCT03796858 | Janssen Pharmaceutica N.V., Belgium | Arthritis, Psoriatic | 2019-03-22 | PHASE3 |
| NCT04394936 | Centre for Human Drug Research, Netherlands|Janssen Pharmaceuticals | Psoriasis Vulgaris | 2020-09-01 | NA |
| NCT03162796 | Janssen Research & Development, LLC | Arthritis, Psoriatic | 2017-08-24 | PHASE3 |
| NCT03573323 | Eli Lilly and Company | Plaque Psoriasis | 2018-11-09 | PHASE4 |
| NCT06663332 | Janssen Research & Development, LLC | Crohns Disease|Colitis, Ulcerative|Arthritis, Psoriatic|Arthritis, Juvenile | 2024-10-29 | PHASE3 |
| NCT07245394 | TIDHI Innovation Inc.|Janssen Inc. | Inflammatory Bowel Disease (IBD)|Crohn Disease (CD)|Ulcerative Colitis (UC)|IBD-unclassified (IBD-U) | 2026-01-29 | |
| NCT07246460 | University of Calgary | Crohn´s Disease of Both Small and Large Intestine | 2025-10-31 | |
| NCT06408935 | Janssen-Cilag Ltd. | Crohn´s Disease | 2024-04-17 | PHASE3 |
| NCT06651489 | Yale University|Janssen Scientific Affairs, LLC | Hailey Hailey Disease | 2025-03-13 | PHASE2 |
| NCT04936308 | Janssen Research & Development, LLC | Arthritis, Psoriatic | 2021-09-28 | PHASE3 |
| NCT02319759 | Janssen Research & Development, LLC | Psoriatic Arthritis | 2015-03-27 | PHASE2 |
| NCT05083182 | Janssen Research & Development, LLC | Arthritis, Juvenile | 2022-08-30 | PHASE3 |
| NCT05071664 | Janssen Research & Development, LLC | Arthritis, Psoriatic | 2021-10-25 | PHASE2 |
| NCT04397263 | Janssen Pharmaceutical K.K. | Crohns Disease | 2020-06-10 | PHASE3 |
| NCT06586281 | University of California, San Diego|Janssen Scientific Affairs, LLC | Psoriatic Arthritis | 2025-06-01 | NA |
| NCT05923073 | Janssen Research & Development, LLC | Crohn´s Disease | 2024-03-13 | PHASE3 |
| NCT05347095 | Janssen-Cilag Ltd. | Fistulizing Crohns Disease|Perianal Crohns Disease | 2022-09-27 | PHASE3 |
| NCT04929210 | Janssen Research & Development, LLC | Arthritis, Psoriatic | 2021-08-30 | PHASE4 |
| NCT07528040 | Shanghai 10th People´s Hospital|Xian-Janssen Pharmaceutical Ltd. | Crohn´s Disease (CD) | 2026-04-15 | |
| NCT03662542 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2018-11-20 | PHASE2 |
| NCT06563323 | Oregon Health and Science University|Janssen Scientific Affairs, LLC|Ohio State University | Pyoderma Gangrenosum|Skin Diseases|Wound Heal|Pyoderma|Skin Ulcer | 2025-02-01 | PHASE2 |
| NCT05784129 | Janssen Research & Development, LLC | Crohn´s Disease | 2023-02-21 | PHASE3 |
| NCT02343744 | Janssen Pharmaceutical K.K. | Pustular Psoriasis | 2015-01-19 | PHASE3 |
| NCT05242471 | Janssen Research & Development, LLC | Crohn´s Disease | 2022-07-22 | PHASE2 |
| NCT03998683 | Janssen-Cilag Ltd. | Psoriasis | 2019-09-03 | PHASE3 |
| NCT04617691 | Janssen Research & Development, LLC | Healthy | 2020-11-30 | PHASE1 |
| NCT06249555 | Alimentiv Inc.|Takeda | Crohn´s Disease | 2024-03-20 | |
| NCT07141004 | Johnson & Johnson Private Limited | Arthritis, Psoriatic | 2025-08-12 | PHASE4 |
| NCT03975153 | Oregon Health and Science University | Pityriasis Rubra Pilaris | 2019-10-03 | PHASE2 |
| NCT04736966 | University of California, San Diego | Alcoholic Liver Disease | 2021-03-03 | PHASE1 |
| NCT07448402 | Caja Costarricense de Seguro Social | Psoriasis|Psoriasis Arthritis|Psoriasis (PsO) | 2026-05 | |
| NCT02207231 | Janssen Research & Development, LLC | Psoriasis | 2014-11-26 | PHASE3 |
| NCT07444060 | Second Affiliated Hospital, School of Medicine, Zhejiang University|People´s Hospital of Chongqing | CD - Crohn´s Disease|Stricture; Bowel|IBD - Inflammatory Bowel Disease | 2026-03-01 | |
| NCT03649971 | Janssen Research & Development, LLC | Adenomatous Polyposis Coli | 2018-11-19 | PHASE1 |
| NCT03158285 | Janssen Research & Development, LLC | Arthritis, Psoriatic | 2017-07-12 | PHASE3 |
| NCT06260163 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2024-01-19 | PHASE3 |
| NCT07352566 | University of California, San Francisco | Psoriasis|Atopic Dermatitis | 2026-01-01 | PHASE4 |
| NCT05242484 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2022-09-19 | PHASE2 |
| NCT06039189 | Janssen Research & Development, LLC | Moderate Plaque Psoriasis | 2023-08-24 | PHASE3 |
| NCT04683029 | Janssen Pharmaceutical K.K. | Scleroderma, Systemic | 2021-02-24 | PHASE2 |
| NCT07499232 | Janssen Research & Development, LLC | Crohn Disease | 2026-04-21 | PHASE3 |
| NCT04376827 | Janssen Research & Development, LLC | Lupus Nephritis | 2020-09-15 | PHASE2 |
| NCT04914429 | Janssen Research & Development, LLC | Psoriasis | 2021-08-25 | PHASE4 |
| NCT07487311 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Inflamatory Bowel Disease | 2026-01-07 | |
| NCT04633447 | Janssen Research & Development, LLC | Giant Cell Arteritis | 2020-12-10 | PHASE2 |
| NCT04533737 | LEO Pharma | Plaque Psoriasis|Psoriasis Vulgaris|Psoriasis | 2020-12-17 | PHASE4 |
| NCT02905331 | Janssen Research & Development, LLC | Psoriasis | 2017-02-28 | PHASE3 |
| NCT03628924 | Janssen Research & Development, LLC | Hidradenitis Suppurativa | 2018-09-04 | PHASE2 |
| NCT05049798 | Janssen Pharmaceutica N.V., Belgium | Arthritis, Psoriatic | 2021-08-25 | |
| NCT07138898 | NYU Langone Health | Rheumatic Disease | 2025-09 | PHASE2 |
| NCT05125679 | Janssen-Cilag Ltd. | Psoriasis | 2021-11-23 | PHASE4 |
| NCT05083078 | Janssen Research & Development, LLC | Arthritis, Psoriatic|Healthy | 2021-11-04 | PHASE1 |
| NCT04882098 | Janssen Research & Development, LLC | Arthritis, Psoriatic | 2021-06-17 | PHASE3 |
| NCT06398106 | University Hospital, Ghent|Belgium Health Care Knowledge Centre | Psoriasis Vulgaris | 2024-12-20 | PHASE4 |
| NCT02397382 | Janssen Research & Development, LLC | Psoriasis | 2015-06-18 | PHASE1 |
| NCT04340076 | Radboud University Medical Center|ZonMw: The Netherlands Organisation for Health Research and Development|Belgium Health Care Knowledge Centre|University Hospital, Ghent | Psoriasis|Psoriasis Vulgaris | 2020-08-20 | PHASE4 |
| NCT04147338 | Janssen Research & Development, LLC | Healthy | 2019-10-30 | PHASE1 |
| NCT05197049 | Janssen Research & Development, LLC | Crohn Disease | 2022-01-19 | PHASE3 |
| NCT04704843 | Janssen Research & Development, LLC | Celiac Disease | 2021-06-17 | PHASE1 |
| NCT04645355 | University of California, San Francisco|Janssen Biotech, Inc. | Psoriasis Guttate|Plaque Psoriasis | 2021-03-01 | PHASE4 |
| NCT05272150 | Janssen Research & Development, LLC | Plaque Psoriasis|Scalp Psoriasis | 2022-07-13 | PHASE3 |
| NCT02207244 | Janssen Research & Development, LLC | Psoriasis | 2014-11-03 | PHASE3 |
| NCT05669833 | University of Pennsylvania|Janssen Scientific Affairs, LLC | Psoriatic Arthritis | 2023-07-14 | PHASE3 |
| NCT05535738 | Wei-Che Ko | Skin Inflammation|Allergic Contact Dermatitis | 2022-11-15 | PHASE2|PHASE3 |
| NCT05858632 | University of California, San Francisco|Janssen Scientific Affairs, LLC | Psoriasis of Scalp | 2023-07-01 | PHASE4 |
| NCT05528510 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2022-09-13 | PHASE3 |
| NCT03536325 | Janssen Pharmaceutical K.K. | Healthy | 2018-05-31 | PHASE1 |
| NCT04061395 | University Medical Center Groningen|Janssen-Cilag Ltd. | Hidradenitis Suppurativa | 2019-10-01 | PHASE2 |
| NCT02103361 | University of California, San Diego|The Organization of Teratology Information Specialists|Janssen Biotech, Inc. | Psoriasis|Pregnancy|Psoriatic Arthritis|Crohn Disease | 2013-11 | |
| NCT02570373 | Janssen Research & Development, LLC | Healthy | 2015-09-25 | PHASE1 |
| NCT04030533 | Janssen Research & Development, LLC | Healthy | 2019-11-29 | PHASE1 |
| NCT04439526 | Janssen-Cilag S.p.A. | Psoriasis | 2020-06-10 | |
| NCT02203032 | Janssen Research & Development, LLC | Psoriasis | 2014-10-07 | PHASE3 |
| NCT02951533 | Janssen-Cilag G.m.b.H | Psoriasis | 2016-12-12 | PHASE3 |
| NCT05004727 | NYU Langone Health|Janssen Scientific Affairs, LLC | Psoriasis | 2022-02-16 | PHASE4 |
| NCT06916390 | Universitaire Ziekenhuizen KU Leuven | Pouchitis | 2026-04-23 | PHASE4 |
| NCT04948398 | Janssen Research & Development, LLC | Adenomatous Polyposis Coli | | |
| NCT04084665 | Rockefeller University|Janssen Scientific Affairs, LLC | Hidradenitis Suppurativa | 2020-06-01 | EARLY_PHASE1 |
| NCT07532486 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Psoriasis | 2024-07-10 | NA |
| NCT05503875 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Immunoclassification|Psoriasis | 2023-01-01 | NA |
| NCT07255781 | University of California, San Diego|Janssen Scientific Affairs, LLC | Psoriasis (PsO)|PsA (Psoriatic Arthritis)|NAFLD (Nonalcoholic Fatty Liver Disease) | 2025-11-30 | |
| NCT01866007 | Janssen Research & Development, LLC | Healthy | 2013-05-09 | PHASE1 |
| NCT07310095 | Xian-Janssen Pharmaceutical Ltd. | Crohn Disease | 2025-12-30 | PHASE4 |
| NCT03451851 | Janssen Research & Development, LLC | Psoriasis | 2018-07-11 | PHASE3 |
| NCT03090100 | Janssen Research & Development, LLC | Psoriasis | 2017-04-27 | PHASE3 |
| NCT01645280 | Janssen Research & Development, LLC | Arthritis, Rheumatoid | 2012-08 | PHASE2 |
| NCT01483599 | Janssen Inc. | Psoriasis | 2011-11-10 | PHASE2 |
| NCT01845987 | Janssen Pharmaceutical K.K. | Palmoplantaris Pustulosis | 2013-06 | PHASE2 |
| NCT01484587 | Janssen Pharmaceutical K.K. | Psoriasis | 2011-08-22 | PHASE1 |
| NCT02325219 | Janssen Pharmaceutical K.K. | Psoriasis | 2014-12-19 | PHASE3 |